Formula & Concentration

Novoeight®, Antihemophilic Factor (Recombinant) For Intravenous Injection. Lyophilized Powder for Solution Initial

Manufacturer

Novo Nordisk

Indications

Novoeight is indicated for use in adults and children with hemophilia A for the control and prevention of bleeding, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.

Novoeight® is not indicated for the treatment of von Willebrand disease.

Product Options

Vial Size

NDC #

250 IU

0169-7825-01

500 IU

0169-7850-01

1000 IU

0169-7810-01

1500 IU

0169-7815-01

2000 IU

0169-7820-01

3000 IU

0169-7830-01

Shelf Life and Storage

Refrigerated up to thirty (30) months – Room temperature up to twelve (12) months / Store Novoeight under refrigeration at a temperature of 36°F-46°F (2°C – 8°C). Novoeight may also be stored at room temperature not to exceed 86°F (30°C).